ストックスクリーナーアプリを入手
3.75
1.35%
0.05
前日終値:
$3.70
開ける：
$3.73
24時間の取引高:
250.15K
Relative Volume:
0.26
時価総額：
$327.89M
収益：
$32.77M
当期純損益:
$-101.98M
株価収益率:
-0.3902
EPS:
-9.6101
ネットキャッシュフロー:
$-112.43M
1週間 パフォーマンス:
+2.46%
1か月 パフォーマンス:
+19.43%
6か月 パフォーマンス:
+35.38%
1年 パフォーマンス:
-66.07%
1日の値動き範囲:
$3.57
$3.78
1週間の範囲:
$3.50
$3.86
52週間の値動き範囲:
$1.35
$26.83
X 4 Pharmaceuticals Inc Stock (XFOR) Company Profile
名前
X 4 Pharmaceuticals Inc
セクター
電話
857-529-8300
住所
61 NORTH BEACON STREET, BOSTON, MA
XFOR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XFOR
X 4 Pharmaceuticals Inc
|
3.75 | 323.52M | 32.77M | -101.98M | -112.43M | -9.6101 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
X 4 Pharmaceuticals Inc Stock (XFOR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-12-12 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2023-08-30 | 再開されました | B. Riley Securities | Buy |
| 2022-12-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-12-12 | 開始されました | Piper Sandler | Overweight |
| 2019-12-23 | 開始されました | Oppenheimer | Outperform |
| 2019-12-18 | 開始されました | ROTH Capital | Buy |
| 2019-12-09 | アップグレード | Citigroup | Neutral → Buy |
| 2019-12-05 | 開始されました | B. Riley FBR | Buy |
| 2019-06-07 | 開始されました | Stifel | Buy |
| 2019-06-05 | 開始されました | Cowen | Outperform |
すべてを表示
X 4 Pharmaceuticals Inc (XFOR) 最新ニュース
X4 Pharmaceuticals (NASDAQ:XFOR) Upgraded to Hold at Wall Street Zen - Defense World
Is X4 Pharmaceuticals Inc. stock positioned for digital transformation2025 Price Action Summary & Comprehensive Market Scan Insights - newser.com
Why X4 Pharmaceuticals Inc. (48Q0) stock remains top ratedWeekly Trend Report & AI Enhanced Trading Alerts - newser.com
Will X4 Pharmaceuticals Inc. stock remain a Wall Street favorite2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
X4 Pharmaceuticals Inc (XFOR) Performance and Fundamentals Dashboard tells a completely different story - Setenews
How to build a dashboard for X4 Pharmaceuticals Inc. stockWeekly Trade Analysis & Growth Oriented Trading Recommendations - newser.com
What moving averages say about X4 Pharmaceuticals Inc.2025 Year in Review & Momentum Based Trading Ideas - newser.com
Why X4 Pharmaceuticals Inc. stock could benefit from AI revolutionPortfolio Return Summary & Fast Gaining Stock Strategy Reports - newser.com
How strong is X4 Pharmaceuticals Inc. stock revenue growthJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - newser.com
Is X4 Pharmaceuticals Inc. stock a buy in volatile marketsDollar Strength & High Yield Equity Trading Tips - newser.com
Will X4 Pharmaceuticals Inc. stock benefit from AI adoptionRisk Management & Technical Pattern Based Buy Signals - newser.com
Will X4 Pharmaceuticals Inc. stock benefit from commodity pricesChart Signals & Community Trade Idea Sharing Platform - newser.com
Fierce Biotech Layoff Tracker 2025: Kite cuts roles; Ventus undertakes 2nd layoff round this year - Fierce Biotech
Using economic indicators to assess X4 Pharmaceuticals Inc. potential2025 Price Targets & Advanced Swing Trade Entry Alerts - newser.com
Is X4 Pharmaceuticals Inc. (48Q0) stock a fit for income portfoliosFed Meeting & Comprehensive Market Scan Reports - newser.com
What analysts say about X4 Pharmaceuticals Inc 48Q0 stockPrice Action Trading & Backtest Your Strategy Before You Risk Money - earlytimes.in
Take off with X4 Pharmaceuticals Inc (XFOR): Get ready for trading - setenews.com
Goldman says healthcare is ripe for stock picking; here's some they like (XLV:NYSEARCA) - Seeking Alpha
What recovery options are there for X4 Pharmaceuticals Inc.Trade Exit Report & Low Drawdown Momentum Trade Ideas - newser.com
How dovish Fed policy supports X4 Pharmaceuticals Inc. (48Q0) stock2025 Market Outlook & Free Risk Controlled Daily Trade Plans - newser.com
PERCEPTIVE ADVISORS LLC Acquires Significant Stake in X4 Pharmac - GuruFocus
What candlestick patterns are forming on X4 Pharmaceuticals Inc.Portfolio Profit Report & Weekly Stock Performance Updates - newser.com
X 4 Pharmaceuticals Inc (XFOR) 財務データ
収益
当期純利益
現金流量
EPS
X 4 Pharmaceuticals Inc (XFOR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Baldry Mark | Chief Commercial Officer |
May 16 '25 |
Buy |
2.48 |
1,032 |
2,561 |
25,337 |
| Ragan Paula | President and CEO |
Jan 24 '25 |
Sale |
0.45 |
76,473 |
34,719 |
1,087,386 |
| Mostafa Adam S. | Chief Financial Officer |
Jan 24 '25 |
Sale |
0.45 |
74,773 |
33,947 |
0 |
| Baldry Mark | Chief Commercial Officer |
Jan 24 '25 |
Sale |
0.45 |
29,159 |
13,241 |
94,123 |
| DiBiase Mary | Chief Operating Officer |
Jan 24 '25 |
Sale |
0.45 |
22,258 |
10,094 |
490,980 |
| Arbet-Engels Christophe | Chief Medical Officer |
Jan 24 '25 |
Sale |
0.45 |
11,624 |
5,284 |
14,207 |
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):